Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization.



Similar documents
Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Lower extremity artery disease. Erich Minar Medical University Vienna

Atherosclerosis is the cause of the vast majority of cases

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

Cilostazol versus Clopidogrel after Coronary Stenting

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Talent Thoracic Stent Graft with THE Xcelerant Delivery System. Expanding the Indications for TEVAR

Credentials for Peripheral Angioplasty: Comments on Society of Cardiac Angiography and Intervention Revisions

The Bioresorbable Vascular Stent Dr Albert Ko

REPORTING STENT PLACEMENT FOR NONOCCLUSIVE VASCULAR DISEASE IN LOWER EXTREMITIES

Duration of Dual Antiplatelet Therapy After Coronary Stenting

How To Use An Ekosonic Endovascular System

Majestic Trial 12 Month Results

Solitaire FR Revascularization Device CODING AND REIMBURSEMENT GUIDE REIMBURSEMENT SUPPORT HOTLINE

Surgeons Role in Atrial Fibrillation

Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): & 16, 2006.

Stroke: Major Public Health Burden. Stroke: Major Public Health Burden. Stroke: Major Public Health Burden 5/21/2012

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

Renal artery stenting: are there any indications left?

What is Vascular Surgery Worth to a Health Care System?

Ultrasound in Vascular Surgery. Torbjørn Dahl

New in Atrial Fibrillation

University of Missouri Kansas City School of Medicine and the Mid America Heart Institute of Saint Luke s Hospital

California Health and Safety Code, Section

Planning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation

American College of Radiology ACR Appropriateness Criteria

Atherosclerosis of the aorta. Artur Evangelista

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November :38

CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT CONCERNING HYBRID REVASCULARIZATION TECHNIQUES IN THE TREATMENT OF MULTILEVEL ARTERIAL OCCLUSIVE DISEASE

1. Utility of transradial approach in endovascular management of chronic mesenteric ischemia

STONY BROOK UNIVERSITY HOSPITAL VASCULAR CENTER CREDENTIALING POLICY

Pulmonary Embolic Disease: Caval Filtration and Other Stuff. Tony P. Smith, M.D. October 2, 2009

MEDICAL POLICY No R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

Wingspan Stent System with Gateway PTA Balloon Catheter

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Delineation of Privileges Department of Surgery/Section of Vascular Surgery. Name: Please print or type

How To Determine Pad

SIR Reporting Standards for the Treatment of Acute Limb Ischemia with Use of Transluminal Removal of Arterial Thrombus

AORTOENTERIC FISTULA. Mark H. Tseng MD Brooklyn VA Hospital February 11, 2005

TREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE?

Patient Information Booklet. Endovascular Stent Grafts: A Treatment for Abdominal Aortic Aneurysms

Non-surgical treatment of severe varicose veins

Imaging of Thoracic Endovascular Stent-Grafts

PATIENT INFORMATION BOOKLET

STROKE OCCURRENCE SYMPTOMS OF STROKE

Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA

A Patient s Guide to Minimally Invasive Abdominal Aortic Aneurysm Repair

Overview of Newer Stent Devices for Aneurysm Treatment

Chronic Thromboembolic Disease. Chronic Thromboembolic Disease Definition. Diagnosis Prevention Treatment Surgical Nonsurgical

Clinical Review Criteria

Ischemia and Infarction

Clinical Study Synopsis

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

When Procedural Support really matters. Navien TM A+ Intracranial Support Catheter

STROKE PREVENTION IN ATRIAL FIBRILLATION

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

OHTAC Recommendation

06 Validation of risk prediction model

What You Should Know About Cerebral Aneurysms

Clinical Medical Policy Varicose Vein Treatment

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

STROKE PREVENTION IN ATRIAL FIBRILLATION. TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: ABBREVIATIONS: BACKGROUND:

INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment

Plumbing 101:! TXA and EMS! Jay H. Reich, MD FACEP! EMS Medical Director! City of Kansas City, Missouri/Kansas City Fire Department!

The Cardiac Society of Australia and New Zealand

Listen to your heart: Good Cardiovascular Health for Life

Coding Updates for 2013: Cardiology

EFSUMB EUROPEAN FEDERATION OF SOCIETIES FOR ULTRASOUND IN MEDICINE AND BIOLOGY Building a European Ultrasound Community

Col league. SMMC Vascular Center Opens A PUBLICATION FOR SOUTHERN MAINE PHYSICIANS

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

SUTTER MEDICAL CENTER, SACRAMENTO Department of Cardiovascular Disease Cardiology - Delineation of Privileges

CARDIA 288 MONTH FOLLOW-UP SUPPLEMENTAL FORM (FORM B) HOSPITALIZATION CASE #: INTERVIEWER ID FY288BIVID2. Page 1 of 6 FY288BH4CN

DISCLOSURE. Atrial Fibrillation Management An Evidence-based Approach OBJECTIVES BACKGROUND AFFIRM 9/16/2015

PIHRATE Trial. Polish-Italian-Hungarian Randomized ThrombEctomy Trial. Dariusz Dudek MD, PhD. On behalf PIHRATE investigators

Varicose veins and venous thrombosis: The latest treatment options

RADIOLOGY 2014 CPT Codes

Catheter insertion of a new aortic valve to treat aortic stenosis

Guidelines for diagnosis and management of acute pulmonary embolism

GENERAL HEART DISEASE KNOW THE FACTS

Understanding your Renal Stent Procedure. A patient Guide (COVER PAGE) TABLE OF CONTENTS (inside front page)

Lifecheque Basic Critical Illness Insurance

Is this pt s brain dysfunction due to ischemia? Onset & progression of sx; location of deficit

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Department of Veterans Affairs VHA DIRECTIVE Veterans Health Administration Washington, DC November 2, 2011

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training

Popliteal artery: to stent or not to stent?

Overview. Total Joint Replacement in the U.S. KP National Total Joint Registry EMR Tools and Outcome Assessment: A Model for Vascular Surgery?

What Is an Arteriovenous Malformation (AVM)?

Vascular Quality Initiative - Carotid Artery Stent. Last Name First Name Middle Initial

Optimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado

Ch. 138 CARDIAC CATHETERIZATION SERVICES CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

WEIGHT LOSS SURGERY. Pre-Clinic Conference Jennifer Kinley, MD 12/15/2010

ECG may be indicated for patients with cardiovascular risk factors

NCD for Lipids Testing

A4.7 Management of a totally occluded central catheter and persistent withdrawal occlusion (PWO)

Transcription:

Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Dr. S. Schepers Dr. F. Van Elst Sint-Trudo Hospital Sint-Truiden Belgium

Chronic aorto-iliac occlusions Thrombolysis thrombectomy Laser Acute aorto-iliac occlusions Thrombolysis Aspiration thrombectomy Mechanical thrombectomy Ultrasoun thrombectomy

Chronic aorto-iliac occlusive disease

Chronic aorto-iliac occlusive disease Treatment evolved from surgical endarterectomy to surgical bypass grafting to endovascular treatment TASC A TASC D PTA Treatment decision: life expectancy age classification surgery co-morbidity previous procedures

Chronic aorto-iliac occlusive disease

Chronic aorto-iliac occlusive disease

Chronic aorto-iliac occlusive disease Thrombolysis and thrombectomy recent occlusion simplify occlusion by conversion into stenosis Laser chronic thrombus plaque dominant lesions definitive therapy! (PTA and/or surgery)

Chronic aorto-iliac occlusive 1. Thrombolysis disease dissolve the occluding thrombus restore perfusion identify underlying cause of arterial/graft occlusion convert major reconstruction to limited procedure lyse thrombi in distal arteries, restoring patency to outflow

2. Laser Chronic aorto-iliac occlusive disease pulse-light to minimize thermal injury slow progression continuous saline infusion to limit dissection

2. Laser Chronic oarto-iliac occlusive disease Percutaneous laser-assisted recanalization of long chronic iliac artery occlusions: primary and mid-term results. (Balzer et al Eur Radiol 2006 Feb) 46 chronic iliac occlusion (average lenght 57.1mm) laser and PTA results: primary technical success rate was 95.3%, with a major complication rate of 6.9% overall primary patency rate was 86.1% follow-up 4 year

Chronic aorto-iliac occlusive disease

Chronic aorto-iliac occlusive disease

Chronic aorto-iliac occlusive disease

Acute aorto-iliac occlusion

Acute aorto-iliac occlusion Risk of morbidity and mortality following open surgical intervention remains high (5 20%) Why? old patients high rate of cardiac and other co-morbidities

Acute aorto-iliac occlusion Need for less invasive intervention: Thrombolytic therapy Aspiration thrombectomy Mechanical thrombectomy (Ultrasound thrombectomy) +/- PTA and/or surgery!

Acute aorto-iliac occlusion Thrombolytic therapy Followed by definitive therapy to address the underlying lesion that caused the occlusion. If not: high risk early rethrombosis 3 clinical trials of thrombolytic therapy versus surgery - Rochester series -Surgery or Thrombolysis for the Ischemic Lower Extremity (STILE) trial -Thrombolysis Or Peripheral Arterial Surgery (TOPAS) trial

ROCHESTER series single center, 114 pt urokinase vs. surgery identical amputation rate different mortality rate due to perioperative cardiopulmonary complications

STILE trial 393 pt in 3 groups: rt-pa, urokinase or surgery finally 2 thrombolytic groups combined endpoints of amputation and death equivalent

STILE trial 2 subgroup analysis: native artery vs. bypass graft occlusion results: rate major amputation higher in native artery occlusions treated with thrombolysis (10% vs 0% after 1 year) lower amputation rate in bypass graft occlusions treated with thrombolysis Conclusion: thrombolysis may be of greatest benefit in patients with acute bypass occlusions of less than 14d

TOPAS trial 544 patients randomized to recombinant urokinase or surgery similar rate of amputationfree survival after 1 year conclusion: acute leg ischemia could be managed with thrombolysis achieving similar amputation and mortality rates but avoiding open surgical procedure

Acute aorto-iliac occlusion Thrombolysis: how to do it? contralateral approach infusion catheter several centimeters into thrombus (single end hole 3F or 4F) low-dose infusion - Urokinase concomitant heparine to prevent pericatheter thrombosis control angiogram at least every 12h patient monitoring hematologic control definitive therapy

Acute aorto-iliac occlusion Complications of thrombolysis bleeding (up to 10%) stroke (2%) distal embolisation (10%) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI) database. (Br J Surgery 2003;90) > 1000 procedures results: amputation free survival rates of 75% at 30 days mortality rate of 12,5% amputation with survival rate of 12,5% high risk for amputation: female, diabetic, neurologic deficit, ischemic heart disease

Acute aorto-iliac occlusion Aspiration thrombectomy = removing small fragments of clot percutaneously - 6 to 8F catheter passed into the occlusion; 50ml syringe attached to the end of the catheter and aspirated at the time it is withdrawn through the occlusion - good result in selected patients with small emboli - acute occlusions in distal peripheral arteries, not in larger arterial branches like iliac vessels

Acute aorto-iliac occlusion Mechanical thrombectomy = breaking up thrombus within the vessel and aspirating it - expensive single-use equipment - only occlusions < 14 days - no comparative trials with surgery or thrombolysis - arterial damage, hematoma (large puncture wounds)

Acute aorto-iliac occlusion Mechanical thrombectomy 1. Amplatz thrombectomy device: - rotational forces to break up thrombus into tiny fragments that simply disperse within the circulation. - clinical significant embolization is rare

Acute aorto-iliac occlusion Mechanical thrombectomy 2. High-pressure saline jet device: - high-pressure saline jets to create a vortex at the catheter tip, so that thrombus is aspirated into a maceration chamber and then removed through a separate channel - AngioJet, Hydrolyser, Oasis - hazard that a great volume of blood can be lost during aspiration!

AngioJet Acute aorto-iliac occlusion

Acute aorto-iliac occlusion

Acute aorto-iliac occlusion

Acute aorto-iliac occlusion

Authors n Conduit, no (%) No (%), success Adjunctive lysis, no(%) Complications (%) Primary Patency (%) Müller- Hülsbeck et al 112 Native, 99 (86) Graft, 16 (14) 80 (71) 20 (18) Embolization (9.8) Dissection (8) Perforation (3.6) Amputation (1.8) Mortality (7) 6 mo (68) 2 yr (60) 3 yr (58) Silva et al 22 Native, 13 (59) Graft, 9 (41) 21 (95) None Hemorrhage (10) Embolism (9) Dissection (5) Occlusion (18) Amputation (5) Mortality (14) Not applicable Wagner et al 50 Native, 39 (78) Graft, 11 (22) 36 (52) 15 (30) Hemorrhage (6) Emboli (6) Dissection (6) Perforation (4) Amputation (8) 1 yr (69) Mortality (0) Kasirajan et al 86 Native, 52 (63) Graft, 31 (37) 70 (84) 50 (58) Hemorrhage (3.5) Embolism (2.3) Dissection (3.5) Perforation (2.3) Amputation (11.6) 6 mo (79)

Acute aorto-iliac occlusion Trellis system = mechanically assisted pharmacologic thrombolysis - drug dispersion and thrombectomy catheter - 2 balloons to isolate treatment zone and maintain thrombolytic agent locally - after inflation change guidewire for dispersion wire - aspirate thrombus after 15min - vessels 4 to 12mm

Acute aorto-iliac occlusion

Acute aort-iliac occlusions Trellis system: Sarac TP et al: Clinical and economic evaluation of the Trellis thrombectomy device for arterial occlusions: preliminary analysis. J Vasc Surg 2004; 39(3):556-9. 26 patients treated results: 58% acute and 42% chronic occlusion 73% infra-inguinal and 27 supra-inguinal technical succes 92% 30-day amputation-free survival rate 96% no difference acute/chronic, infra/supra-inguinal conclusion: Early results suggests that it is as effective as traditional catheter-directed thrombolysis. Furthermore, there were no bleeding complications, likely the result of the Trellis device requiring shorter procedure and infusion times.

CONCLUSION (1) The practical management of aorto-iliac occlusions remains a challenge, as it involves one of the most complex decision pathways in vascular surgery. Thrombolysis and thrombectomy offers a less invasive approach to thrombotic occlusions, with the opportunity to address the unmasked, causative lesions directly. Correction of these lesions can often be accomplished through an endovascular approach such as PTA(S).

CONCLUSION (2) Even when after thrombolysis and/or thombectomy a bypass graft must be placed, the procedure can frequently be performed in an elective setting after adequate patient preparation. A successfull outcome depends upon an experienced team with access to the full range of available techniques, and the ability to use them appropriately in individually selected patients.